CIC
MLAB icon

Carnegie Investment Counsel’s Mesa Laboratories MLAB Stock Holding History

Carnegie Investment Counsel’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,350
Closed -$270K – 391
2018
Q3 		$270K Buy
+1,350
New +$272K 0.02% 300

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Carnegie Investment Counsel's MLAB Position: Q4 2018 in Review

Carnegie Investment Counsel sold out of Mesa Laboratories (MLAB) in Q4 2018, closing a stake of 1,350 shares — an estimated $270K sold.

Carnegie Investment Counsel first reported a position in MLAB in Q3 2018 and held it in 1 quarter. The position peaked at $270K in Q3 2018. 109 funds tracked by Wall St. Rank hold MLAB as of Q4 2018.

  • Carnegie Investment Counsel reported no remaining Mesa Laboratories position as of Q4 2018 after selling out during the quarter.
  • Carnegie Investment Counsel sold 1,350 Mesa Laboratories shares in Q4 2018, an estimated $270K.
  • Carnegie Investment Counsel first reported a position in Mesa Laboratories in Q3 2018 and held it in 1 quarter.
  • Carnegie Investment Counsel's Mesa Laboratories position peaked at $270K in Q3 2018.
  • 109 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2018.

Based on Carnegie Investment Counsel's 13F filing for Q4 2018, filed 14 Feb 2019.